Correction to: Efficacy of canakinumab on AA amyloidosis in late-onset NLRP3-associated autoinflammatory disease with an I574F somatic mosaic mutation.
作者信息
Itamiya Takahiro, Komai Toshihiko, Kanda Hiroko, Nagafuchi Yasuo, Chang Hyangri, Shibata Shota, Ishiura Hiroyuki, Shoda Hirofumi, Toda Tatsushi, Fujio Keishi
机构信息
Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Immune-Mediated Diseases Therapy Center, The University of Tokyo, Tokyo, Japan.
出版信息
Clin Rheumatol. 2022 Jul;41(7):2239. doi: 10.1007/s10067-022-06158-3.
PMID:35362833
Abstract
摘要
Zotero 插件